Masimo Corp. Stock
Masimo Corp. Stock
Masimo Corp. gained 0.510% compared to yesterday.
Masimo Corp. is currently one of the favorites of our community with 15 Buy predictions and no Sell predictions.
As a result the target price of 172 € shows a very positive potential of 51.48% compared to the current price of 113.55 € for Masimo Corp..
Pros and Cons of Masimo Corp. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
M***** P*******
Cons
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Masimo Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Masimo Corp. | 0.510% | -2.574% | -10.343% | -29.450% | -30.783% | -17.298% | -47.913% |
| Icu Medical Inc. | 0.000% | 0.806% | -4.580% | -14.966% | -14.966% | -13.194% | -26.471% |
| Neogen Corp. | -1.640% | -4.688% | 19.608% | -47.414% | -49.167% | - | - |
| Haemonetics Corp. | 0.000% | 0.000% | -1.439% | - | - | - | - |
Comments
Masimo (NASDAQ:MASI) had its price target raised by analysts at BTIG Research from $198.00 to $200.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MASI provided by MarketBeat
Masimo (NASDAQ:MASI) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $198.00 price target on the stock.
Show more
Ratings data for MASI provided by MarketBeat
Masimo (NASDAQ:MASI) had its price target lowered by analysts at Wells Fargo & Company from $190.00 to $187.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for MASI provided by MarketBeat
News
4D Advisors Offloads $7.6 Million in Masimo (MASI) Stock, Selling 45,000 Shares
On Nov. 14, 2025, 4D Advisors, LLC disclosed in a regulatory filing that it sold out its entire position in Masimo (NASDAQ:MASI). The sale was valued at $7.57 million.
According to a filing with the
